Literature DB >> 24571832

MR anatomy of deep brain nuclei with special reference to specific diseases and deep brain stimulation localization.

Ryan Telford1, Surjith Vattoth2.   

Abstract

Diseases affecting the basal ganglia and deep brain structures vary widely in etiology and include metabolic, infectious, ischemic, and neurodegenerative conditions. Some neurologic diseases, such as Wernicke encephalopathy or pseudohypoparathyroidism, require specific treatments, which if unrecognized could lead to further complications. Other pathologies, such as hypertrophic olivary degeneration, if not properly diagnosed may be mistaken for a primary medullary neoplasm and create unnecessary concern. The deep brain structures are complex and can be difficult to distinguish on routine imaging. It is imperative that radiologists first understand the intrinsic anatomic relationships between the different basal ganglia nuclei and deep brain structures with magnetic resonance (MR) imaging. It is important to understand the "normal" MR signal characteristics, locations, and appearances of these structures. This is essential to recognizing diseases affecting the basal ganglia and deep brain structures, especially since most of these diseases result in symmetrical, and therefore less noticeable, abnormalities. It is also crucial that neurosurgeons correctly identify the deep brain nuclei presurgically for positioning deep brain stimulator leads, the most important being the subthalamic nucleus for Parkinson syndromes and the thalamic ventral intermediate nucleus for essential tremor. Radiologists will be able to better assist clinicians in diagnosis and treatment once they are able to accurately localize specific deep brain structures.

Entities:  

Keywords:  MR imaging; deep brain nuclei; deep brain stimulation

Mesh:

Year:  2014        PMID: 24571832      PMCID: PMC4202840          DOI: 10.15274/NRJ-2014-10004

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  21 in total

1.  Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases.

Authors:  Donald A Collie; David M Summers; Robin J Sellar; James W Ironside; Sarah Cooper; Martin Zeidler; Richard Knight; Robert G Will
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients.

Authors:  G Zuccoli; M Gallucci; J Capellades; L Regnicolo; B Tumiati; T Cabada Giadás; W Bottari; J Mandrioli; M Bertolini
Journal:  AJNR Am J Neuroradiol       Date:  2007-08       Impact factor: 3.825

3.  Pattern of cortical changes in sporadic Creutzfeldt-Jakob disease.

Authors:  H J Tschampa; K Kallenberg; H A Kretzschmar; B Meissner; M Knauth; H Urbach; I Zerr
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

4.  Localization of the subthalamic nucleus: optimization with susceptibility-weighted phase MR imaging.

Authors:  A T Vertinsky; V A Coenen; D J Lang; S Kolind; C R Honey; D Li; A Rauscher
Journal:  AJNR Am J Neuroradiol       Date:  2009-06-09       Impact factor: 3.825

Review 5.  MR imaging findings in hepatic encephalopathy.

Authors:  A Rovira; J Alonso; J Córdoba
Journal:  AJNR Am J Neuroradiol       Date:  2008-06-26       Impact factor: 3.825

6.  Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism.

Authors:  Deepak Gupta; Jitender Saini; Chandrasekharan Kesavadas; P Sankara Sarma; Asha Kishore
Journal:  Neuroradiology       Date:  2010-04-01       Impact factor: 2.804

7.  Symptomatic characteristics of parkinsonism and the width of substantia nigra pars compacta on MRI according to ischemic changes in the putamen and cerebral white matter: implications for the diagnosis of vascular parkinsonism.

Authors:  H Tohgi; S Takahashi; T Abe; K Utsugisawa
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

8.  Wallerian degeneration after cerebral infarction: evaluation with sequential MR imaging.

Authors:  M J Kuhn; D J Mikulis; D M Ayoub; B E Kosofsky; K R Davis; J M Taveras
Journal:  Radiology       Date:  1989-07       Impact factor: 11.105

9.  Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease.

Authors:  R Duara; D A Loewenstein; E Potter; J Appel; M T Greig; R Urs; Q Shen; A Raj; B Small; W Barker; E Schofield; Y Wu; H Potter
Journal:  Neurology       Date:  2008-12-09       Impact factor: 9.910

10.  MR imaging - an unreliable and potentially misleading diagnostic modality in patients with intracerebral calcium depositions. Case report.

Authors:  Dusko Kozic; Ljiljana Todorovic-Djilas; Robert Semnic; Ivana Miucin-Vukadinovic; Milos Lucic
Journal:  Neuro Endocrinol Lett       Date:  2009       Impact factor: 0.765

View more
  5 in total

1.  A within-coil optical prospective motion-correction system for brain imaging at 7T.

Authors:  Phillip DiGiacomo; Julian Maclaren; Murat Aksoy; Elizabeth Tong; Mackenzie Carlson; Bryan Lanzman; Syed Hashmi; Ronald Watkins; Jarrett Rosenberg; Brian Burns; Timothy W Skloss; Dan Rettmann; Brian Rutt; Roland Bammer; Michael Zeineh
Journal:  Magn Reson Med       Date:  2020-02-20       Impact factor: 4.668

2.  Bilateral surgical damage of the central tegmental tract resulting in bilateral hypertrophic olivary degeneration: An MRI case report.

Authors:  Silvia Lana; Chiara Ganazzoli; Girolamo Crisi
Journal:  Neuroradiol J       Date:  2017-06-26

Review 3.  Clinical Application of Brain MRI in the Diagnostic Work-up of Parkinsonism.

Authors:  Frederick J A Meijer; Bozena Goraj; Bastiaan R Bloem; Rianne A J Esselink
Journal:  J Parkinsons Dis       Date:  2017       Impact factor: 5.568

4.  A novel imaging method for correlating 2D light microscopic data and 3D volume data based on block-face imaging.

Authors:  Yuki Tajika; Tohru Murakami; Keiya Iijima; Hiroki Gotoh; Maiko Takahashi-Ikezawa; Hitoshi Ueno; Yuhei Yoshimoto; Hiroshi Yorifuji
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

5.  In vivo Population Averaged Stereotaxic T2w MRI Brain Template for the Adult Yucatan Micropig.

Authors:  Stephano J Chang; Andrea J Santamaria; Francisco J Sanchez; Luz M Villamil; Pedro Pinheiro Saraiva; Jose Rodriguez; Yohjans Nunez-Gomez; Ioan Opris; Juan P Solano; James D Guest; Brian R Noga
Journal:  Front Neuroanat       Date:  2020-11-13       Impact factor: 3.856

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.